Metabolic-Associated Fatty Liver Disease (MAFLD) is associated with immune activation, increased epicardial fat volume, and steatohepatitis among people with HIV in a Thai cohort.
Win Min HanTanakorn ApornpongPairoj ChattranukulchaiSarawut SiwamogsathamHay Mar Su LwinJedsadakorn BoonrungsirisapThanathip WichiansanSivaporn GatechompolSasiwimol UbolyamStephen J KerrPisit TangkijvanichAnchalee AvihingsanonPublished in: HIV medicine (2023)
The complex relationship between MAFLD and immune activation, steatohepatitis, and epicardial fat tissue suggests an increased risk of advanced liver disease and CVDs beyond the traditional risk factors in people living with HIV with fatty liver disease.